Their presence could play an important role in diagnosing and treating herpetic disease.
Steady growth in the prevalence of this deceptively simple condition will expose half the world’s population to visual impairment. Here’s what to expect and what we should do.
Corneal Collagen Crosslinking | Meibomian Gland dysfunction | Descemet’s Membrane Endothelial Keratoplasty
The simplest option is often the best solution.
To understand and treat this common lid condition, make sure you’re clear on its many different presentations.
While always important to lens wear, the eyelids also play a vital role in GP lens success.
Does a relatively new phenomenon help explain contact lens discomfort?
Which came first, the dysfunction or the discomfort? Researchers aren’t sure, but clinicians need to manage them simultaneously.
The human microbiome supports our existence, but it also serves as the source of infection. Resistance is on the rise, and clinicians have to prescribe carefully.
Do you know how to work with insurance companies to achieve the biggest bang for your buck?
Research on lesion size in superficial punctate keratitis could mean better technology.
Your approach to these four clinical challenges will influence the course of therapy and its outcome.
Here's a snapshot of what's happening in the industry.
Adenoviral infections remain the number one cause of urgent care visits to eye care practitioners' offices.
Extended wear of fluid-filled scleral contact lenses may change corneal nerve function in certain patients.
The tear film is the nexus of many seemingly distinct structures and clinical entities. Be mindful of such links when managing OSD.
A new study suggests incidence of keratitis is highest in patients who live in suburban areas.
A patient presents with all the classic signs of dry eye disease. But what if it’s not that simple?
Can one progressive eye disease teach us how to best treat another?
Here is a snapshot of what's happening in the industry
The individual susceptibility of fungal organisms means a wide range of therapeutic options exist.
This collagen-rich tissue is emerging as a new method for managing EBMD and recurrent corneal erosion. How does it perform clinically?
A new British study suggests a link between dry eye and chronic pain in female patients.
The rise of an advanced form poses serious risks to patients. Here's how to get it under control—in the cornea and in the clinic.